Key result
In patients with coronary artery disease, the presence of metabolic syndrome was associated with significantly lower fasting serum adiponectin concentrations (8.83 vs 14.48 μg/mL, p=0.009).
Cross-Sectional (n=98)
No
Absolute Event Rate: 8.83% vs 14.48%
p-value: p=0.009
In patients with coronary artery disease, fasting serum adiponectin is inversely correlated with the presence and severity of metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Lower adiponectin in CAD with metabolic syndrome warrants no clinical action; leaves open its prognostic utility in prospective cohorts.
Wang et al. (2010) conducted a cross-sectional in Coronary Artery Disease (n=98). Metabolic syndrome vs. No metabolic syndrome was evaluated on Fasting serum adiponectin concentration (p=0.009). In patients with coronary artery disease, the presence of metabolic syndrome was associated with significantly lower fasting serum adiponectin concentrations (8.83 vs 14.48 μg/mL, p=0.009).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: